Myeloid Cell‐Triggered In Situ Cell Engineering for Robust Vaccine‐Based Cancer Treatment.

MLA

Li, Wen‐Hao, et al. “Myeloid Cell‐Triggered In Situ Cell Engineering for Robust Vaccine‐Based Cancer Treatment.” Advanced Materials, vol. 36, no. 16, Apr. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1002/adma.202308155.

APA

Li, W., Su, J., Zhang, B., Zhao, L., Zhuo, S., Wang, T., Hu, H., & Li, Y. (2024). Myeloid Cell‐Triggered In Situ Cell Engineering for Robust Vaccine‐Based Cancer Treatment. Advanced Materials, 36(16), 1–13. https://doi.org/10.1002/adma.202308155

Chicago

Li, Wen‐Hao, Jing‐Yun Su, Bo‐Dou Zhang, Lang Zhao, Shao‐Hua Zhuo, Tian‐Yang Wang, Hong‐Guo Hu, and Yan‐Mei Li. 2024. “Myeloid Cell‐Triggered In Situ Cell Engineering for Robust Vaccine‐Based Cancer Treatment.” Advanced Materials 36 (16): 1–13. doi:10.1002/adma.202308155.